[496] SIX YEARS OF ON DEMAND LAM±ADV COMBINATION THERAPY SIGNIFICANTLY REDUCES THE DEVELOPMENT AND PROGRESSION OF ESOPHAGEAL VARICES IN PATIENTS WITH HBeAg-NEGATIVE CIRRHOSIS